Multianalyte Algorithmic Assays | Nexomic Limited



Multianalyte algorithmic assays from Nexomic Limited merge high-dimensional omics data with intelligent algorithms to create highly sensitive and specific assays for early disease detection, monitoring, and personalized care.



https://nexomic.com/

ESMO 2025: AI biomarkers move from promise to practice



At this year’s ESMO Congress in Berlin, one message was clear: AI-based biomarkers are exiting the lab and entering real clinical decisions. From digital pathology to CT radiomics and multi-omics, teams showed practical ways to read response earlier and adapt treatment more precisely.






Blog source Url:- https://nexomic.com/blog/esmo-....2025-ai-biomarkers-m

Tumor-agnostic Biomarkers | Nexomic Limited



Tumor-agnostic biomarkers discovered by Nexomic Limited provide universal targets for cancer therapies regardless of tumor origin, enabling broader treatment applications and improved patient outcomes across multiple cancer types.



https://nexomic.com/

Ai Multi-omics Biomarker Discovery | Nexomic Limited

AI Multi-omics biomarker discovery at Nexomic Limited leverages advanced computational and biological approaches to identify critical biomarkers across multiple omics layers, enabling precision medicine and transformative healthcare solutions.

https://nexomic.com/

Join Us: Help Shape the Future of Precision Medicine

We’re expanding our team and looking for curious, driven people who want to be part of the science that is reshaping medicine. If you’re excited by discovery, data, and the chance to see your work translate into real-world impact, we’d love to meet you.

https://nexomic.com/blog/we-are-hiring